相关实验视频
Updated: Jun 29, 2025
08:35
Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
7.9K
一种强大的第二代双降解BCL-2和BCL-xL的开发和晶体结构
Digant Nayak1, Dongwen Lv1, Yaxia Yuan1
1Department of Biochemistry & Structural Biology and Greehey Children's Cancer Research Institute, University of Texas Health Science Center at San Antonio, San Antonio, TX, 78229, USA.
Nature communications
|March 29, 2024
概括
研究人员开发了WH244,它是一种强大的PROTAC降解剂,向涉及癌症的BCL-xL和BCL-2蛋白. 结构性见解指导了这种改进的治疗药物抗癌药物耐药性的合理设计.
科学领域:
- 结构生物学 结构生物学
- 化学生物学 化学生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 过度表达BCL-xL和BCL-2蛋白质有助于癌症的发展和对治疗的抗性.
- 化向嵌合体 (PROTAC) 技术提供了一种新的方法来降解蛋白.
研究的目的:
- 为了确定VHL/753b/BCL-xL和VHL/753b/BCL-2三元复合物的晶体结构.
- 了解差异化目标参与的结构基础,并指导改进的PROTAC的合理设计.
主要方法:
- 用X射线晶体学来确定三元复杂结构.
- 生物物理测定和基于细胞的研究,以验证功能重要性和评估降解.
- 新型 PROTACs 的结构引导的合理设计.
主要成果:
- 为VHL/753b/BCL-xL和VHL/753b/BCL-2确定了不同的三元复杂架构.
- 确定了关键的界面相互作用,对目标降解至关重要.
- 设计WH244,一种新的降解剂,在细胞分析中对BCL-xL和BCL-2具有增强的效力.
结论:
- 对PROTAC-目标相互作用的结构洞察力对于合理的药物设计至关重要.
- 结合结构生物学,理性设计和基于细胞的验证的简化方法可以加速开发有效的基于PROTAC的癌症治疗方法.
- WH244代表了针对癌症治疗的BCL-xL/BCL-2的有希望的进展.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
01:15Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K